BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6319860)

  • 1. Distinct molecular forms of opiate binding in the frog brain.
    Puget A; Jauzac P; Meunier JC
    Life Sci; 1983; 33 Suppl 1():199-202. PubMed ID: 6319860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical separation of the agonist and antagonist forms of a mu opiate receptor?
    Jauzac P; Puget A; Meunier JC
    Life Sci; 1983; 33 Suppl 1():195-8. PubMed ID: 6319859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5'-Guanylylimidodiphosphate decreases affinity for agonists and apparent molecular size of a frog brain opioid receptor in digitonin solution.
    Mollereau C; Pascaud A; Baillat G; Mazarguil H; Puget A; Meunier JC
    J Biol Chem; 1988 Dec; 263(34):18003-8. PubMed ID: 2848020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization of two molecular forms of the frog brain opioid receptor.
    Puget A; Frances B; Jauzac P; Meunier JC
    Neuropeptides; 1984 Dec; 5(1-3):129-32. PubMed ID: 6099480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Opiate receptor(s) of the frog brain: soluble-phase separation of the macromolecular complexes of an agonist and an antagonist].
    Puget A; Meunier JC
    C R Seances Acad Sci III; 1983; 296(10):475-8. PubMed ID: 6307492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of two molecular forms of a mu-opioid receptor type by sodium ions, manganese ions and by guanyl-5'-yl imidodiphosphate.
    Jauzac P; Frances B; Puget A; Moisand C; Meunier JC
    J Recept Res; 1986; 6(1):1-25. PubMed ID: 3012080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
    Frances B; Puget A; Moisand C; Meunier JC
    Eur J Pharmacol; 1990 Jul; 189(1):1-9. PubMed ID: 2171960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate.
    Kurowski M; Rosenbaum JS; Perry DC; Sadée W
    Brain Res; 1982 Oct; 249(2):345-52. PubMed ID: 6291717
    [No Abstract]   [Full Text] [Related]  

  • 9. Opiate receptor thermodynamics: agonist and antagonist binding.
    Hitzemann R; Murphy M; Curell J
    Eur J Pharmacol; 1985 Jan; 108(2):171-7. PubMed ID: 2984022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanine nucleotides inhibit binding of agonists and antagonists to soluble opiate receptors.
    Koski G; Simonds WF; Klee WA
    J Biol Chem; 1981 Feb; 256(4):1536-8. PubMed ID: 6257676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
    Sadée W; Rosenbaum JS; Herz A
    J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein.
    Porthé G; Francés B; Verrier B; Cros J; Meunier JC
    Life Sci; 1988; 43(6):559-67. PubMed ID: 2841553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
    Tolkovsky AM
    Mol Pharmacol; 1982 Nov; 22(3):648-56. PubMed ID: 6296657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
    Geary WA; Wooten GF
    J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors.
    Wang XJ; Fan SG; Ren MF; Han JS
    Life Sci; 1989; 45(2):117-23. PubMed ID: 2545992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of digitonin on the binding of opiate agonists and antagonists to membrane-bound and soluble opioid binding sites.
    Itzhak Y; Hiller JM; Gioannini TL; Simon EJ
    Brain Res; 1984 Jan; 291(2):309-15. PubMed ID: 6320961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization, solubilization and purification of an opioid receptor from the brain of the frog Rana ridibunda.
    Pascaud A; Mollereau C; Puget A; Baillat G; Mazarguil H; Meunier JC
    NIDA Res Monogr; 1986; 75():5-8. PubMed ID: 2828997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
    Richards ML; Sadée W
    Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of adrenal medullary opioid receptors. I. Binding of opioids to adrenal medullary opioid receptors].
    Murase H; Kamikubo K; Murayama M; Yasuda K; Tsurumi K; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1987 Jun; 63(6):727-40. PubMed ID: 2822499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.